Docetaxel in combination with irinotecan (CPT-11) in platinum-resistant paclitaxel-pretreated ovarian cancer.
about
Overcoming platinum resistance in ovarian carcinoma.Gemcitabine-oxaliplatin (GEMOX) as salvage treatment in pretreated epithelial ovarian cancer patients.Docetaxel and irinotecan in recurrent or metastatic head and neck cancer: a phase 2 trial of the Eastern Cooperative Oncology Group.A phase I study of irinotecan and pegylated liposomal doxorubicin in recurrent ovarian cancer (Tohoku Gynecologic Cancer Unit 104 study)
P2860
Docetaxel in combination with irinotecan (CPT-11) in platinum-resistant paclitaxel-pretreated ovarian cancer.
description
2005 nî lūn-bûn
@nan
2005 թուականի Սեպտեմբերին հրատարակուած գիտական յօդուած
@hyw
2005 թվականի սեպտեմբերին հրատարակված գիտական հոդված
@hy
2005年の論文
@ja
2005年論文
@yue
2005年論文
@zh-hant
2005年論文
@zh-hk
2005年論文
@zh-mo
2005年論文
@zh-tw
2005年论文
@wuu
name
Docetaxel in combination with ...... xel-pretreated ovarian cancer.
@ast
Docetaxel in combination with ...... xel-pretreated ovarian cancer.
@en
type
label
Docetaxel in combination with ...... xel-pretreated ovarian cancer.
@ast
Docetaxel in combination with ...... xel-pretreated ovarian cancer.
@en
prefLabel
Docetaxel in combination with ...... xel-pretreated ovarian cancer.
@ast
Docetaxel in combination with ...... xel-pretreated ovarian cancer.
@en
P2093
P1433
P1476
Docetaxel in combination with ...... xel-pretreated ovarian cancer.
@en
P2093
Antonios Lagadas
Aristides Polyzos
Christos Kosmas
Christos Kosmidis
Helen Toufexi
Kostas Kandilis
Nicholas Malamos
Nicholas Ziras
Panagiotis Ginopoulos
Vassilis Georgoulias
P304
P407
P577
2005-09-01T00:00:00Z